Agilent Technologies Property, Plant, and Equipment 2010-2025 | A
Agilent Technologies property, plant, and equipment from 2010 to 2025. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
- Agilent Technologies property, plant, and equipment for the quarter ending January 31, 2025 was $1.816B, a 38.2% increase year-over-year.
- Agilent Technologies property, plant, and equipment for 2024 was $1.778B, a 40% increase from 2023.
- Agilent Technologies property, plant, and equipment for 2023 was $1.27B, a 15.45% increase from 2022.
- Agilent Technologies property, plant, and equipment for 2022 was $1.1B, a 16.4% increase from 2021.
| Agilent Technologies Annual Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2024 | $1,778 |
| 2023 | $1,270 |
| 2022 | $1,100 |
| 2021 | $945 |
| 2020 | $845 |
| 2019 | $850 |
| 2018 | $822 |
| 2017 | $757 |
| 2016 | $639 |
| 2015 | $604 |
| 2014 | $631 |
| 2013 | $1,134 |
| 2012 | $1,164 |
| 2011 | $1,006 |
| 2010 | $980 |
| 2009 | $845 |
| Agilent Technologies Quarterly Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2025-01-31 | $1,816 |
| 2024-10-31 | $1,778 |
| 2024-07-31 | $1,446 |
| 2024-04-30 | $1,371 |
| 2024-01-31 | $1,314 |
| 2023-10-31 | $1,270 |
| 2023-07-31 | $1,211 |
| 2023-04-30 | $1,184 |
| 2023-01-31 | $1,147 |
| 2022-10-31 | $1,100 |
| 2022-07-31 | $1,054 |
| 2022-04-30 | $1,010 |
| 2022-01-31 | $974 |
| 2021-10-31 | $945 |
| 2021-07-31 | $905 |
| 2021-04-30 | $884 |
| 2021-01-31 | $866 |
| 2020-10-31 | $845 |
| 2020-07-31 | $846 |
| 2020-04-30 | $836 |
| 2020-01-31 | $844 |
| 2019-10-31 | $850 |
| 2019-07-31 | $839 |
| 2019-04-30 | $827 |
| 2019-01-31 | $829 |
| 2018-10-31 | $822 |
| 2018-07-31 | $801 |
| 2018-04-30 | $798 |
| 2018-01-31 | $792 |
| 2017-10-31 | $757 |
| 2017-07-31 | $716 |
| 2017-04-30 | $675 |
| 2017-01-31 | $653 |
| 2016-10-31 | $639 |
| 2016-07-31 | $623 |
| 2016-04-30 | $610 |
| 2016-01-31 | $594 |
| 2015-10-31 | $604 |
| 2015-07-31 | $587 |
| 2015-04-30 | $593 |
| 2015-01-31 | $610 |
| 2014-10-31 | $631 |
| 2014-07-31 | $1,142 |
| 2014-04-30 | $1,139 |
| 2014-01-31 | $1,129 |
| 2013-10-31 | $1,134 |
| 2013-07-31 | $1,139 |
| 2013-04-30 | $1,147 |
| 2013-01-31 | $1,163 |
| 2012-10-31 | $1,164 |
| 2012-07-31 | $1,139 |
| 2012-04-30 | $996 |
| 2012-01-31 | $1,007 |
| 2011-10-31 | $1,006 |
| 2011-07-31 | $1,000 |
| 2011-04-30 | $1,004 |
| 2011-01-31 | $982 |
| 2010-10-31 | $980 |
| 2010-07-31 | $957 |
| 2010-04-30 | $831 |
| 2010-01-31 | $837 |
| 2009-10-31 | $845 |
| 2009-07-31 | $839 |
| 2009-04-30 | $821 |
| 2009-01-31 | $831 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $30.991B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.138B | 28.03 |
| Boston Scientific (BSX) | United States | $152.812B | 38.26 |
| Stryker (SYK) | United States | $145.981B | 30.52 |
| EssilorLuxottica (ESLOY) | France | $128.807B | 0.00 |
| Medtronic (MDT) | Ireland | $107.246B | 15.66 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.937B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.673B | 27.10 |
| ResMed (RMD) | United States | $35.644B | 26.77 |
| GE HealthCare Technologies (GEHC) | United States | $32.281B | 15.33 |
| Terumo (TRUMY) | Japan | $28.175B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.624B | 16.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.817B | 12.09 |
| Insulet (PODD) | United States | $18.083B | 70.99 |
| Baxter (BAX) | United States | $16.011B | 11.95 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.408B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.962B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.751B | 22.82 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 14.04 |
| Prestige Consumer Healthcare (PBH) | United States | $4.312B | 19.21 |
| Perrigo (PRGO) | Ireland | $3.684B | 9.34 |
| ICU Medical (ICUI) | United States | $3.516B | 25.93 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.417B | 14.88 |
| Envista Holdings (NVST) | United States | $3.012B | 25.03 |
| QuidelOrtho (QDEL) | United States | $2.459B | 16.96 |
| GN Store Nord (GNNDY) | Denmark | $2.020B | 16.73 |
| LeMaitre Vascular (LMAT) | United States | $1.841B | 41.16 |
| AtriCure (ATRC) | United States | $1.544B | 0.00 |
| Neogen (NEOG) | United States | $1.300B | 16.64 |
| Green Thumb Industries (GTBIF) | United States | $1.234B | 27.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.162B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.130B | 11.47 |
| BioLife Solutions (BLFS) | United States | $1.062B | 0.00 |
| InMode (INMD) | Israel | $0.990B | 9.06 |
| Phibro Animal Health (PAHC) | United States | $0.901B | 11.53 |
| Evolus (EOLS) | United States | $0.651B | 0.00 |
| CeriBell (CBLL) | United States | $0.616B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.592B | 0.00 |
| Owens & Minor (OMI) | United States | $0.540B | 4.48 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.405B | 0.00 |
| Surmodics (SRDX) | United States | $0.389B | 0.00 |
| Omeros (OMER) | United States | $0.368B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.356B | 13.11 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.270B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.267B | 47.50 |
| Verano Holdings (VRNOF) | United States | $0.266B | 0.00 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| ZimVie (ZIMV) | United States | $0.256B | 11.63 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Canopy Growth (CGC) | Canada | $0.246B | 0.00 |
| Quanterix (QTRX) | United States | $0.214B | 0.00 |
| Biote (BTMD) | United States | $0.205B | 5.75 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| High Tide (HITI) | Canada | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.25 |
| TriSalus Life Sciences (TLSI) | United States | $0.167B | 0.00 |
| Brainsway (BWAY) | Israel | $0.167B | 52.18 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.33 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| Exagen (XGN) | United States | $0.111B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.080B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| Fonar (FONR) | United States | $0.078B | 10.91 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| United Health Products (UEEC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Apyx Medical (APYX) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 58.50 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.74 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |